<p>Additional relevant references:</p><p>Furosemide and cross-reactivity with sulfa-containing antibiotics</p><p>Original reports</p><p>1) Ahmad A, Ramakrishnan A, McLean MA et al (2002) Use </p><p> of optical biosensor technology to study immunological cross-reactivity between differen</p><p> t sulfonamide drugs. Anal Biochem 300:177–184</p><p>2) Bigby M, Jick S, Jick H et al (1986) Drug-induced cutaneous reactions. A report from the</p><p>Boston Collaborative Drug Surveillance Program on 15,438 consecutive inpatients, 1975 </p><p> to 1982. JAMA 256:3358–3363 </p><p>3) Lowe J, Gray J, Henry DA et al (1979) Adverse reactions to frusemide in hospital </p><p> inpatients. Br Med J 2:360–362 </p><p>4) Murray MD, Deer MM, Ferguson JA et al (2001) Open-label randomized trial </p><p> of torsemide compared with furosemide therapy for patients with heart failure. Am J Med</p><p>111:513–520 </p><p>5) Ramsay LE, McInnes GT, Hettiarachchi J et al (1978) Bumetanide and frusemide: a </p><p> comparison of dose-response curves in healthy men. Br J Clin Pharmacol 5:243–247 </p><p>6) Sfakianakis GN, Sfakianaki E, Georgiou M et al (2009) A renal protocol for all ages and </p><p> all indications -- mercapto-acetyl-triglycine (MAG3) with simultaneous injection of </p><p> furosemide (MAG3-F0): a 17-year experience. Semin Nucl Med 39:156–173 </p><p>7) Tuzel IH (1981) Comparison of adverse reactions to bumetanide and furosemide. J Clin </p><p>Pharmacol 21:615–619 </p><p>Reviews</p><p>Page 1 of 5 8) Asbury MJ, Gatenby PBB, O’Sullivan S et al (1972) Bumetanide: potent new ‘loop’ </p><p> diuretic. Br Med J 1:211–213 </p><p>9) DiNocolantionio JJ (2012) Should torsemide be the loop diuretic of choice in systolic </p><p> heart failure? Future Cardiol 8:707–728 </p><p>10) Halstenson CE, Matzke GR (1983) Bumetanide: a new loop diuretic (Bumex, Roche </p><p>Laboratories). Drug Intell Clin Pharm 17):786–797</p><p>11) Molnar J, Somberg JC (2009) The clinical pharmacology of ethacrynic acid. Am J Ther </p><p>16:86–92 </p><p>12) Somberg JC, Molnar J (2009) The management of acute heart </p><p> failure and diuretic therapy. Am J Ther 16:93–97 </p><p>Case reports</p><p>13) Earl G, Davenport J, Narula J (2003) Furosemide challenge in patients with heart failure </p><p> and adverse reactions to sulfa-containing diuretics. Ann Intern Med 138:358–359 </p><p>14) Nguyen BD, Roarke MC, Howard OH (2010) Ethacrynic acid as potential drug for </p><p> diuretic renography in instance of sulfonamide allergy. Clin Nucl Med 35:547–549 </p><p>15) Wall GC, Bigner D, Craig S (2003) Ethacrynic acid and the sulfa sensitive patient. Arch </p><p>Intern Med 163:116–117 </p><p>Case series of furosemide allergy</p><p>16) Buchanan N, Cane RD (1977) Frusemid-induced [sic] pancreatitis. Br Med J 2:1417 </p><p>17) Burry JN, Lawrence JR (1976) Phototoxic blisters from high frusemide dosage. Br J </p><p>Dermatol 94:495–499 </p><p>Page 2 of 5 18) Kennedy AC, Lyell A (1976) Acquired epidermolysis bullosa due to high-dose </p><p> frusemide. Br Med J 1:1509–1510 </p><p>19) Machtey I (1968) Sudden death after intramuscular frusemide. Lancet 2:1301 </p><p>20) Panayiotou BN, Prasad MV, Zaman MN (1997) Frusemide-induced bullous pemphigoid. </p><p>Br J Clin Pract 51:49–50 </p><p>21) Siddigui MA, Zaman MN (1995) Recurrent and chronic leg ulcers secondary to </p><p> furosemide-induced bullous pemphigoid. J Am Geriatr Soc 43:1183–1184 </p><p>22) Strunge P (1975) Letter: frusemide-induced pancreatitis? Br Med J 3:434 </p><p>Case reports of furosemide allergy</p><p>23) Alim N, Patel JY (2009) Rapid oral desensitization to furosemide. Ann Allergy Asthma </p><p>Immunol 103:538 </p><p>24) Baz K, Ikizoglu G, Kaya TI et al (2002) Furosemide-induced bullous pemphigoid. J Eur </p><p>Acad Dermatol Venereol 16:81–82 </p><p>25) Call T, Malarkey WB, Thomas FB (1977) Acute pancreatitis secondary to furosemide </p><p> with associated hyperlipidemia. Am J Dig Dis 22:835–838 </p><p>26) Castel T, Gratacos R, Castro J et al (1981) Bullous pemphigoid induced by furosemide. </p><p>Clin Exp Dermatol 6:635–638 </p><p>27) Cobb MW (1989) Furosemide-induced eruption simulating Sweet's syndrome. J Am </p><p>Acad Dermatol 21:339–343 </p><p>28) Dagli AJ, Moos JS (1983) Sudden death following injection of frusemide: a case report. </p><p>Indian J Med Sci 38:49–50 </p><p>Page 3 of 5 29) Dominguez-Ortega J, Martinez-Alonso JC, Dominguez-Ortega C et al (2003) </p><p>Anaphylaxis to oral furosemide. Allergol Immunopathol 31:345–347 </p><p>30) Ebringer A, Adam WR, Parkin JD (1969) Bullous haemorrhagic eruption associated with </p><p> frusemide. Med J Aust 1:768–771 </p><p>31) Fellner MJ, Katz JM (1976) Occurrence of bullous pemphigoid after furosemide therapy. </p><p>Arch Dermatol 112:75–77 </p><p>32) Gibson TP, Blue P (1970) Erythema multiforme and furosemide therapy. JAMA </p><p>212:1709</p><p>33) Guin JD (1980) Bullous haemorrhagic eruption: a drug-induced disease. Cutis 25:534–</p><p>536 </p><p>34) Hansbrough JR, Wedner HJ, Chaplin DD (1987) Anaphylaxis to intravenous furosemide. </p><p>J Allergy Clin Immunol 80:538–541 </p><p>35) Hendericks WM, Ader RS (1977) Furosemide-induced cutaneous necrotizing vasculitis. </p><p>Arch Dermatol 113:375 </p><p>36) Jones PE, Oelbaum MH (1975) Frusemide-induced pancreatitis. Br Med J 1:133–134 </p><p>37) Juang P, Page RL 2nd, Zolty R (2006) Probable loop diuretic-induced pancreatitis in a </p><p> sulfonamide-allergic patient. Ann Pharmacother 40:128–134 </p><p>38) Koch CA, Mazzaferri EL, Larry JA et al (1996) Bullous pemphigoid after treatment with </p><p> furosemide. Cutis 58:340–344 </p><p>39) Lee JJ, Downham TF 2nd (2006) Furosemide-induced bullous pemphigoid: case report </p><p> and review of literature. J Drugs Dermatol 5:562–564 </p><p>40) Macmillan AL (1973) Generalised pustual drug rash. Dermatologica 146:285–291 </p><p>Page 4 of 5 41) Noce R, Paredes BE, Pichler WJ et al (2000) Acute generalized exanthematic pustulosis </p><p>(AGEP) in a patient treated with furosemide. Am J Med Sci 320:331–333 </p><p>42) Steinvinkel P, Alvestrand A (1988) Loop diuretic-induced pancreatitis with rechallenge </p><p> in a patient with malignant hypertension and renal insufficiency. Acta Med Scand </p><p>224:89–91 </p><p>43) Sugita K, Kabashima K, Nakashima D et al (2008) Papuloerythroderma of Ofuji induced </p><p> by furosemide. J Am Acad Dermatol 58:S54–55 </p><p>44) Takeichi S, Kubo Y, Arase S et al (2009) Brunsting-Perry type </p><p> localized bullous pemphigoid, possibly induced by furosemide administration and sun </p><p> exposure. Eur J Dermatol 19:500–503 </p><p>45) Wilson AE, Mehra SK, Gomersall CR et al (1967) Acute pancreatitis associated with </p><p> frusemide therapy. Lancet 1:105 </p><p>46) Wright AA, Vesta KS, Stark JE et al (2010) Stevens-Johnson syndrome associated with </p><p> furosemide: a case report. J Pharm Pract 23:367–370 </p><p>47) Zugerman C, La Voo EJ (1980) Erythema multiforme caused by oral furosemide. Arch </p><p>Dermatol 116:518–519 </p><p>Page 5 of 5</p>